Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication

Virology

Volumn 237, Issue 2, 1997, Pages 228-236

  Verhoef, Koen ^a   Koper, Maaike ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; PROVIRUS; VIRUS MUTANT; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030703134     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8786     Document Type: Article

References (58)

1. Back N. K. T., Nijhuis M., Keulen W., Boucher C. A. B., Oude Essink B. B., van Kuilenburg A. B. P., Van Gennip A. H., Berkhout B. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15:1996;4040-4049.
2. Bayer P., Kraft M., Ejchart A., Westendorp M., Frank R., Rosch P. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247:1995;529-535.
3. Berkhout B., Jeang K. T. Trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: A quantitative analysis. J. Virol. 63:1989;5501-5504.
4. Berkhout B., Silverman R. H., Jeang K. T. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell. 59:1989;273-282.
5. Brake D. A., Goudsmit J., Krone W. J., Schammel P., Appleby N., Meloen R. H., Debouck C. Characterization of murine monoclonal antibodies to the Tat protein from human immunodeficiency virus type 1. J. Virol. 64:1990;962-965.
6. Chang L. J., Zhang C. Infection and replication of Tat-human immunodeficiency viruses: Genetic analyses of LTR and Tat mutations in primary and long-term human lymphoid cells. Virol. 211:1995;157-169.
7. Churcher M. J., Lamont C., Hamy F., Dingwall C., Green S. M., Lowe A. D., Butler J. G., Gait M. J., Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 Tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 230:1993;90-110.
8. Ciminale V., Felber B. K., Campbell M., Pavlakis G. N. A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res. Hum. Retroviruses. 6:1990;1281-1287.
9. Desai K., Loewenstein P. M., Green M. Isolation of a cellular protein that binds to the human immunodeficiency virus Tat protein and can potentiate transactivation of the viral promoter. Proc. Natl. Acad. Sci. USA. 88:1991;8875-8879.
10. Dimitrov D. S., Willey R. L., Sato H., Chang L.-J., Blumenthal R., Martin M. A. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67:1993;2182-2190.
11. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A., Valerio R. Human immunodeficiency virus 1 Tat protein binds trans-activating-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA. 86:1989;6925-6929.
12. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A. HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:1990;4145-4153.
13. Duan L., Oakes J. W., Ferraro A., Bagasra O., Pomerantz R. J. tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells. Virol. 199:1994;474-478.
14. Frankel A. D., Bredt D. S., Pabo C. O. Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science. 240:1988;70-73.
15. 1. J. Mol. Biol. 250:1995;672-688.
16. Fridell R. A., Harding L. S., Bogerd H. P., Cullen B. R. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology. 209:1995;347-357.
17. Garcia J. A., Harrich D., Gaynor R. B. Functional domains required for Tat-induced transcriptional activation of the HIV 1 long terminal repeat. EMBO J. 7:1988;3143-3147.
18. Gutheil W. G., Subramanyam M., Flentke G. R., Sanford D. G., Munoz E., Huber B. T., Bachovchin W. W. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): A possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. USA. 91:1994;6594-6598.
19. Hauber J., Malim M., Cullen B. Mutational analysis of the conserved basic domain of human immunodeficiency virus Tat protein. J. Virol. 63:1989;1181-1187.
20. Herrmann C. H., Rice A. P. Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology. 197:1993;601-608.
21. Huang L. M., Joshi A., Willey R., Orenstein J., Jeang K. T. Human immunodeficiency viruses regulated by alternative trans-activators: Genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:1994;2886-2896.
22. Jeang K. T. Theoretical Biology and Biophysics. Human Retroviruses and AIDS 1995: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. 1995;Los Alamos National Laboratory, Los Alamos.
23. Jeang K. T., Chun R., Lin N. H., Gatignol A., Glabe C. G., Fan H. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:1993;6224-6233.
24. Kashanchi F., Piras G., Radonovich M. F., Duvall J. F., Fattaey A., Chiang C.-M., Roeder R. G., Brady J. N. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature. 367:1994;295-299.
25. Klaver B., Berkhout B. Comparison of 5′ and 3′ long terminal repeat promoter function in human immunodeficiency virus. J. Virol. 68:1994;3830-3840.
26. Koken S. E. C., Greijer A. E., Verhoef K., van Wamel J., Bukrinskaya A. G., Berkhout B. Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem. 269:1994a;8366-8375.
27. Koken S. E. C., van Wamel J., Berkhout B. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus. Gene. 144:1994b;243-247.
28. Kozak M. The scanning model for translation: An update. J. Cell Biol. 108:1989;229-241.
29. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82:1985;488-492.
30. Kuppuswamy M., Subramanian T., Srinivasan A., Chinnadurai G. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17:1989;3551-3561.
31. Loret E. P., Vives E., Ho P. S., Rochat H., van Rietschoten J., Johnson W. C. Jr. Activating region of HIV-1 Tat protein: Vacuum UV circular dichroism and energy minimization. Biochemistry. 30:1991;6013-6023.
32. Luznik L., Kraus G., Guatelli J., Richman D., Wong-Staal F. Tat-independent replication of human immunodeficiency viruses. J. Clin. Invest. 95:1995;328-332.
33. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., Morfeldt-Manson L., Asjo B., Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:1989;901-910.
34. Modesti N., Garcia J., Debouck C., Peterlin M., Gaynor R. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression. New Biol. 3:1991;759-768.
35. Mujeeb A., Bishop K., Peterlin B. M., Turck C., Parslow T. G., James T. L. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat. Proc. Natl. Acad. Sci. USA. 91:1994;8248-8252.
36. Myers G., Wain-Hobson S., Henderson L. E., Korber B., Jeang K. T., Pavlakis G. N. Theoretical Biology and Biophysics. Human Retroviruses and AIDS 1994: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. 1994;Los Alamos National Laboratory, Los Alamos.
37. Orsini M. J., Debouck C. M. Inhibition of human immunodeficiency virus type 1 and type 2 Tat function by transdominant Tat protein localized to both the nucleus and cytoplasm. J. Virol. 70:1996;8055-8063.
38. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
39. Pearson L., Garcia J., Wu F., Modesti N., Nelson J., Gaynor R. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA. 87:1990;5079-5083.
40. LAIMALELI. Virology. 185:1991;661-672.
41. Rice A. P., Carlotti F. Mutational analysis of the conserved cysteine region of the human immunodeficiency virus type 1 tat protein. J. Virol. 64:1990;1864-1868.
42. Ruben S., Perkins A., Purcell R., Joung K., Sia R., Burghoff R., Haseltine W., Rosen C. Structural and functional analysis of human immunodeficiency virus Tat protein. J. Virol. 63:1989;1-8.
43. Sabino E., Pan L.-Z., Cheng-Mayer C., Mayer A. Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasispecies to short-term tissue culture isolates: An analysis of tat and C2-V3 env regions. AIDS. 8:1994;901-909.
44. Sadaie M. R., Rappaport J., Wong-Staal F. Missense mutations in an infectious human immunodeficiency viral genome: Functional mapping of tat and identification of the rev splice acceptor. Proc. Natl. Acad. Sci. USA. 85:1988;9224-9228.
45. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
46. Seed B., Sheen J. Y. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 67:1988;271-277.
47. Seigel L. J., Ratner L., Josephs S. F., Derse D., Feinberg M. B., Reyes G. R., O'Brien S. J., Wong-Staal F. Trans-activation induced by human T-lymphotrophic virus type III (HTLV-III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity. Virology. 148:1986;226-231.
48. Sheline C. T., Milocco L. H., Jones K. A. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes Dev. 5:1991;2508-2520.
49. Subramanian R. A., Cohen E. A. Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 68:1994;6831-6835.
50. Verhoef K., Klein A., Berkhout B. Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell. Virology. 225:1996;316-327.
51. Veschambre P., Simard P., Jalinot P. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo. J. Mol. Biol. 250:1995;169-180.
52. Wu F., Garcia J., Sigman D., Gaynor R. Tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes Dev. 5:1991;2128-2140.
53. Wu-Baer F., Sigman D., Gaynor R. B. Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat. Proc. Natl. Acad. Sci. USA. 92:1995;7153-7157.
54. Yu L., Loewenstein P. M., Zhang Z., Green M. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69:1995a;3017-3023.
55. Yu L., Zhang Z., Loewenstein P. M., Desai K., Tang Q., Mao D., Symington J. S., Green M. Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain. J. Virol. 69:1995b;3007-3016.
56. Zhou Q., Sharp P. A. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14:1995;321-328.
57. Zhou Q., Sharp P. A. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science. 274:1996;605-610.
58. Zhu M., Duan L., Pomerantz R. J. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells. AIDS Res. Hum. Retroviruses. 12:1996;1093-1101.